387 omega toxin-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous non-metal compounds | 11 | 6.4 | 1.73× | q = 0.07 | |
| Organic oxygen compounds | 9 | 5.9 | 1.53× | q = 0.23 | |
| Homogeneous metal compounds | 10 | 14.5 | 0.69× | q = 0.15 | |
| Nucleosides, nucleotides, and analogues | 0 | 8.2 | 0 | q = 3.4e-4 | |
| Organosulfur compounds | 1 | 0.6 | 1.64× | not tested | |
| Lipids and lipid-like molecules | 4 | 3.3 | 1.22× | not tested | |
| Organic nitrogen compounds | 1 | 0.9 | 1.06× | not tested | |
| Organic acids and derivatives | 4 | 4.6 | 0.87× | not tested | |
| Benzenoids | 1 | 2.2 | 0.46× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 16 |
| DB03740 | NDG | N-acetyl-alpha-D-glucosamine | 11 |
| DB04454 | DBB | Alpha-Aminobutyric Acid | 6 |
| DB02379 | BGC | Beta-D-Glucose | 1 |
| DB03766 | PPI | Propanoic acid | 1 |
| DB09157 | CO2 | Carbon dioxide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 40 |
| PIO | [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate | 38 |
| CL | CHLORIDE ION | 20 |
| PA8 | 1,2-DIOCTANOYL-SN-GLYCERO-3-PHOSPHATE | 20 |
| ZNmetal | ZINC ION | 13 |
| GYV | 2-acetamido-1-O-carbamoyl-2-deoxy-alpha-D-glucopyranose | 12 |
| NDG | 2-acetamido-2-deoxy-alpha-D-glucopyranose | 12 |
| 65I | (9R,12R)-15-amino-12-hydroxy-6,12-dioxo-7,11,13-trioxa-12lambda~5~-phosphapentadecan-9-yl undecanoate | 8 |
| GYT | BIS-(2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYLOXYCARBONYL)-4,7,10-TRIOXA-1,13-TRIDECANEDIAMINE | 8 |
| MAN | alpha-D-mannopyranose | 8 |
| NAmetal | SODIUM ION | 8 |
| BR | BROMIDE ION | 7 |
| I3C | 5-amino-2,4,6-triiodobenzene-1,3-dicarboxylic acid | 7 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 7 |
| 44E | (2R)-3-(phosphonooxy)propane-1,2-diyl dihexanoate | 5 |
| 6O9 | (2S)-2-(acetyloxy)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}propyl pentanoate | 4 |
| 6OE | (2S)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(hexanoyloxy)propyl hexanoate | 4 |
| GYU | 2-acetamido-2-deoxy-1-O-(propylcarbamoyl)-alpha-D-glucopyranose | 4 |
| SCN | THIOCYANATE ION | 4 |
| SIA | N-acetyl-alpha-neuraminic acid | 4 |